Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Agri ; 33(3): 200-202, 2021 Jul.
Article in Turkish | MEDLINE | ID: mdl-34318922

ABSTRACT

The complications of bone anchored hearing aids are very rare. The most seen postoperative complication is soft tissue reaction locally occuring around the titanium implant. Chronic headache is a rarely seen complication related to bone anchored hearing aids application. We presented a patient having complaints of chronic headache and burning sensation after bone anchored hearing aids application. Follow up for one year after the operation, despite the local and systemic therapies, there was no improvement of symptoms and the device was compulsorily removed. This rare complication of bone anchored hearing aids application is reviewied in the literature and probable reasons of failure are discussed.


Subject(s)
Chronic Pain , Hearing Aids , Chronic Pain/etiology , Chronic Pain/therapy , Humans , Titanium
2.
Braz J Otorhinolaryngol ; 87(3): 305-309, 2021.
Article in English | MEDLINE | ID: mdl-31753779

ABSTRACT

INTRODUCTION: Various graft materials have been used in the tympanoplasty technique. Cartilage grafts are being used increasingly in recent years. OBJECTIVE: The aim of this study was to present the comparative outcomes of the perichondrium-preserved palisade island graft technique previously defined by ourselves. METHODS: We retrospectively compared the hearing and graft success rates in 108 patients with chronic otitis media, who had undergone cartilage tympanoplasty, where both island and perichondrium-preserved palisade graft techniques were used. RESULTS: The success rates among the study and the control groups with regard to graft take were 97% and 93%, respectively. No significant difference was observed between the groups with regard to the postoperative mean pure tone values, improvement in air-bone gaps and reduction in air-bone gaps to under 20dB. However, better results were observed in the study group. CONCLUSION: The perichondrium-preserved palisade island graft technique is an easy method with high graft success rates and hearing outcomes.


Subject(s)
Tympanic Membrane Perforation , Tympanoplasty , Cartilage/transplantation , Hearing , Hearing Tests , Humans , Retrospective Studies , Treatment Outcome , Tympanic Membrane Perforation/surgery
3.
World J Plast Surg ; 7(2): 253-255, 2018 May.
Article in English | MEDLINE | ID: mdl-30083513

ABSTRACT

Since identical twins occur as a result of the division of one egg, they have the same genetic structure. Therefore, their phenotypes and sex are also always the same. However, due to the effect of environmental factors, some of the characteristics of twins living in different regions appear to develop differently. In our case of 17-year-old maternal twins, we emphasized that nasal pathologies carried a genetic background in terms of their similarity in septum deviation and external nasal deformity, which were determined to have occurred without a history of trauma. The article has also been presented at 10th Turkish Rhinology Congress, 22-25 May, 2014 Antalya, Turkey.

4.
J Int Adv Otol ; 14(1): 22-26, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28639555

ABSTRACT

OBJECTIVE: The purpose of this study was to examine the anti-ototoxic impact of Ginkgo biloba extract and lycopene on the model of cisplatin-induced ototoxicity in rats. MATERIALS AND METHODS: Thirty-two Wistar albino rats were examined with the distortion product otoacoustic emission (DPOAE) test (MADSEN Capella2 ; GN Otometrics, ICS Medical, Chicago USA), and they were randomly divided into four groups. Group 1 (n=8) was defined as the healthy control group. Cisplatin was given intraperitoneally as single dose of 12 mg/kg to group 2 (n=8), group 3 (n=8), and group 4 (n=8). Group 2 was determined as ototoxic control group. G. biloba extract (100 mg/kg) was given to group 3, and 20 mg/kg lycopene was given to group 4 with orogastric feeding tube daily for 10 days. DPOAE test was repeated on day 10 on all the groups. Finally, histopathological examination was performed. The study has been lead in agreement with the principles by the Institutional Animal Care and Use Committee Review Board at Kocaeli University Medical Center (KOÜ HADYEK- 1/9-14). The animals were treated in accordance with protocols approved by this committee. RESULTS: When DPOAE tests were compared, there was no significant difference in the four groups before the application (p > 0.05). At the end of day 10, in groups 2 to 4, statistically significant changes were observed (p < 0.05). According to the cisplatin group, a significant increase in the DP-grams on G. biloba and lycopene groups was observed (p < 00.5). Corti organ and spiral ganglion neurons of groups 1, 3, and 4 were observed to have weak expression. Strong reactions were determined in organum spirale and some spiral ganglions of the cisplatin group. The striae vascularis damage on group 2 was found to be more significant more compared with groups 3 and 4. CONCLUSION: There is a protective effect of G. biloba and lycopene on cisplatin-dependent ototoxic rat model.


Subject(s)
Cisplatin/toxicity , Ear Diseases/chemically induced , Lycopene/adverse effects , Plant Extracts/adverse effects , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/toxicity , Antioxidants/adverse effects , Antioxidants/therapeutic use , Cisplatin/administration & dosage , Cochlea/drug effects , Cochlea/pathology , Ear Diseases/pathology , Ear Diseases/physiopathology , Ear Diseases/prevention & control , Ginkgo biloba , Injections, Intraperitoneal , Lycopene/administration & dosage , Lycopene/therapeutic use , Male , Organ of Corti/drug effects , Otoacoustic Emissions, Spontaneous/drug effects , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Spiral Ganglion/drug effects
5.
Kulak Burun Bogaz Ihtis Derg ; 25(6): 343-5, 2015.
Article in Turkish | MEDLINE | ID: mdl-26572178

ABSTRACT

OBJECTIVES: This study aims to show the effects of nasal continuous positive airway pressure (CPAP) treatment on platelet activation in patients with severe obstructive sleep apnea syndrome (OSAS). PATIENTS AND METHODS: Forty-six patients (29 males, 17 females; mean age 48.2±7.6 years; range 40 to 56 years) with severe OSAS with apnea/hypopnea index (AHI) ≥30 were included in this study. Complete blood counts were analyzed and mean platelet volume (MPV) values were compared in patients before and after CPAP treatment at six months. RESULTS: The mean MPV values before CPAP were 8.9±1.3 (p<0.001), while the mean values were 7.7±1.1 (p<0.001) at six months after CPAP treatment in patients with severe OSAS. There was a statistically significant decrease in the MPV values after CPAP treatment. Patients' number of platelets which was measured six months after the CPAP treatment increased at a significant level compared to baseline (p<0.001). CONCLUSION: Continuous positive airway pressure treatment caused a significant decrease in the MPV values in patients with severe OSAS. As a negative acute phase reactant, MPV can be used as a marker to exert the cardioprotective effect of CPAP.


Subject(s)
Sleep Apnea, Obstructive/blood , Adult , Continuous Positive Airway Pressure , Female , Humans , Male , Mean Platelet Volume/methods , Middle Aged , Polysomnography , Severity of Illness Index , Sleep Apnea, Obstructive/physiopathology , Sleep Apnea, Obstructive/therapy
6.
Aesthetic Plast Surg ; 39(6): 888-91, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26392372

ABSTRACT

UNLABELLED: The nasolabial cyst also known as Klestadt's cyst is a rare non-odontogenic soft tissue lesion of the nasal alar region. Aetiopathogenesis of the nasolabial cysts is controversial. Embryonic and developmental theories were considered at pathogenesis of the nasolabial cyst. In addition, surgical or non-surgical trauma is one of the possible theories. This paper reports a case of a 33-year-old male patient that presented with bilateral nasolabial cysts after rhinoplasty and alar base reduction. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266.


Subject(s)
Cysts/etiology , Lip Diseases/etiology , Nose Diseases/etiology , Rhinoplasty/adverse effects , Adult , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...